Table 2.
Laboratory findings of total patients and subdivided in with or without myocardial injury.
| Laboratory findings | Total (n = 254) |
Myocardiacl injury (+) (n = 73) |
Myocardial injury (−) (n = 181) |
p value |
|---|---|---|---|---|
| Hemoglobin (g/dL) | 14.6(13.4–15.5) | 14.7 (13.5–15.7) | 14.6(13.4–15.4) | NS |
| Platelets count (× 103/μL) | 207(166.0–275.0) | 199(165.3–240) | 222.0(166.0–280.0) | NS |
| Leukocytes count (× 103/μL) | 7.8(5.7–11.0) | 9.5(7.5–18.8) | 10.2(7.4–13.9) | <0.001 |
| Neutrophils (× 103/μL) | 6.1(3.9–9.1) | 7.9(6.4–11.5) | 5.6(3.5–8.6) | <0.001 |
| Lymphocytes (× 103/μL) | 0.8(0.6–1.2) | 0.7(0.5–1.2) | 0.9(0.7–1.3) | <0.021 |
| hs-CRP (mg/L) | 126.6(61.3–200.1) | 188.2(127.0–220.7) | 103.4(50.2–194.0) | <0.001 |
| CK-MB (ng/mL) | 2.3(0.7–7.1) | 4.5(2.0–12.8) | 1.3(0.7–7.1) | <0.001 |
| Fibrinogen (g/L) | 5.5(4.3–6.69 | 5.3(4.3–6.3) | 5.6(4.3–6.6) | NS |
| ESR (mm/hr) | 40.5(30.0–48.0) | 35.0(30.0–47.0) | 41(23.0–48.0) | NS |
| Ferritin (ng/mL) | 690(376.0–1168.0) | 939(428.1–1354.0) | 583(350.0–1141.5) | <0.001 |
| Glucose (mg/dL) | 109.5(89.0–148.0) | 128.4(89.0–170.4) | 109.0(88.0–139.0) | 0.033 |
| Sodium (mmol/L) | 137.0(134.0–140) | 137.0(132.4–140.0) | 137.0(134.0–140.0) | NS |
| Potassium (mmol/L) | 4.0(3.7–4.4) | 4.1(3.8–4.4) | 4.0(3.7–4.4) | NS |
| Albumin (g/dL) | 3.5 SD 0.5 | 3.2 SD 0.5 | 3.6 SD 0.4 | <0.001 |
| LDH (U/L) | 397(280.0–501.0) | 430.8(344.4–527.1) | 346.0(271.8–485.0) | <0.001 |
| Creatinine (mg/dL) | 0.9(0.7–1.1) | 1.0(0.8–1.2) | 0.8(0.7–1.0) | 0.002 |
| BUN (mg/dL) | 16.9(13.0–29.2) | 21.0(14.9–29.2) | 15.4(12.0–21.0) | <0.001 |
| Total Cholesterol (mg/dL) | 114.0(92.0–139.0) | 105.5883.0–139.0) | 117.0(100.0–139.0) | NS |
| Triglycerides (mg/dL) | 130.0(98.3–183.3) | 145.0(101.8–196.5) | 125.0(96.8–182.8) | NS |
| LDL (mg/dL) | 72.8(53.1–93.4) | 37.6(30.6–60.3) | 77.6(66.0–96.1) | <0.001 |
| ALT (U/L) | 43.0(26.0–60.2) | 43.7(24.5–88.0) | 40.8(26.0–59.0) | NS |
| AST (U/L) | 45.3(31.0–65.5) | 58.7(35.8–84.5) | 43.5(29.6–60.0) | 0.008 |
| D-dimer (μg/mL) | 0.6(0.4–1.3) | 0.6(0.3–3.5) | 0.6(0.4–1.3) | NS |
| hs-cTnI (pg/mL) | 9(5.0–17) | 34.9(22.2–95.7) | 9.0(4.3–9.0) | <0.001 |
| hs-cTnI after 7 day (pg/mL) | 6.5(3.0–24.8) | 66.3(20.4–208.0) | 3.9(2.5–6.1) | <0.001 |
| NT pro-BNP (pg/mL) | 196.0(52.0–2095.0) | 704.5(246.0–2130.8) | 100.0(42.6–361.0) | <0.001 |
| NT pro-BNP after 7 day (pg/mL) | 230.0(101.5–1563.0) | 2250.0(596.0–9408.5) | 129.0(68.8–581.3) | 0.004 |
Each value represents the median (interquartile range), mean ± SD or the number (%), p < 0.05 was considered statistically significant. Hemoglobin (Hb), Creatine kinase-MB (CK-MB), high-sensitivity C-reactive Protein (hs-CRP), Erythrocyte Sedimentation Rate (ESR), Lactate Dehydrogenase (LDH), Blood Urea Nitrogen (BUN), Low-Density Lipoprotein (LDL), Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), high-sensitivity cardiac Troponin I (hs-cTnI), N-terminal pro-B-type Natriuretic Peptide (NT pro-BNP).